The purpose of this study is to assess the ability of long-duration low intensity therapeutic ultrasound (LITUS) to alleviate knee Osteoarthritis pain over a 24-week period. The primary objective of this study is to evaluate the analgesic effect of LITUS in subjects suffering from knee Osteoarthritis pain. Secondary objectives are to assess the ability of LITUS to improve joint function.
This is a 24-week study to clinically evaluate the effectiveness of the wireless Sustained Acoustic Medicine (SAM) device combined with diclofenac on symptoms of patients suffering from knee osteoarthritis. The class-II device, sam®, has been FDA-cleared for home use. On the first day of the study, baseline data will be collected as patients report pain score before treatment. During the following 24 weeks, patients will self-apply their assigned treatment for the 4 hours daily. Each day of the study, pain scores will be recorded immediately before application of SAM device as well as at the completion of treatment. Assessments on quality of life \& function, depression \& anxiety, and sleep will be performed prior to the patient beginning the protocol, at 8 weeks, 16 weeks and at the conclusion of the protocol. Over 300 subjects will be recruited from neighboring communities to the study sites. The study is designed to reach a target patient population which includes rural citizens and socioeconomic disadvantaged individuals.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
300
Patients apply the SAM Ultrasonic Diathermy Device daily for 1-4 hours of continuous therapeutic ultrasound at 3 megahertz(MHz) frequency and 0.132 Watts/cm\^2 with 2.5% Diclofenac patches.
Patients apply the SAM Ultrasonic Diathermy Device daily for 1-4 hours with 0% diclofenac patches.
Topical pain relief-gel worn for 4 hours at least 5 days a week via SAM patch.
Orthopaedic Foundation
Stamford, Connecticut, United States
RECRUITINGZetrOZ Systems
Trumbull, Connecticut, United States
RECRUITINGCayuga Medical Center - Medical Pain Consultants
Dryden, New York, United States
RECRUITINGChange in Pain Units on a Scale (0-10) 0 Being Least, 10 Being Worst Pain From Baseline
Change in the self-described pain units on a scale by patient at baseline and post-treatment.
Time frame: Through study completion, average of 24 weeks.
Change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
WOMAC questionnaire will be utilized (Western Ontario and McMaster Universities Arthritis Index) at baseline and post-treatment to calculate the change in scores. WOMAC was divided into 3 categories: pain, stiffness, function and total score. The pain category consists of five scores from 0 - 4, 0 being no pain 4 is worst pain possible, for a range of 0 - 20 points. The stiffness category consists of two scores from 0 - 4, 0 being no stiffness 10 is worst stiffness possible for a range of 0 - 8 points. The function score consists of 17 scores from 0 - 4, 0 being normal function and 10 is severely limited function, for a range of 0 - 68 points. Total score is the sum of pain, stiffness, and function scores (range of 0 - 96).
Time frame: Through study completion, average of 24 weeks.
Change in Global Rating of Change (GROC) on a Scale (-7 to +7)
Subject-reported change in overall pain on a scale, -7 = worst, +7 = best.
Time frame: Through study completion, average of 24 weeks.
Change in the Pain & Sleep Questionnaire (PSQ-3)
Subject-reported rating of impact of pain on sleep on a scale from 0 no impact, to 100 greatest impact.
Time frame: Through study completion, average of 24 weeks.
Change in Depression Anxiety Stress Scale (DASS21)
Subject-reported measures of depression, anxiety, and stress on a scale of 0-3, 0 being not applicable, 1 meaning applicable to some degree, 2 meaning applicable often, and 3 meaning applicable most of the time. Questions are divided into three categories: depression, anxiety, and stress.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Ultrasound gel without additional pain relief medication worn for 4 hours at least 5 days a week via SAM patch.
Time frame: Through study completion, average of 24 weeks.